solana tokenized equities went from $25m to $1.2b in 12 months. 47x. faster than defi summer 2020. 96% market share in tokenized stocks across xstocks, sunrise, and backpack. ethereum has 6x more total RWA TVL but only $380m in tokenized equities. solana owns 76% of that vertical. spacex named solana in their S-1 filing for employee equity distribution. first s&p 500 caliber company to reference a specific smart contract platform in regulatory docs. the $100t global equity market is picking its settlement layer and the early data is not ambiguous
circle just dropped a case study on @Zebec_HQ
$500M+ a year in payroll running through Zebec rails.
stablecoin payroll is not a niche thing anymore, 13,000 people get paid this way already
4 days.
8 new prediction market integrations.
100s of new markets.
The DeFi moment for prediction markets is here, and itโs powered by Chainlink.
Explore the ecosystem ๐งต๐
$LINK is the bet on full financial tokenization.
Swift brings the banks.
DTCC brings securities.
Chainlink becomes the routing, data and settlement layer for everything onchain.
Aggressive bull targets:
1 year: $150
2 years: $500
3 years: $1,000+
If global assets tokenize, #Chainlink is not middleware
Itโs the financial internet
picture this
8 of the world's biggest problems getting solved in the next 12-18 months
1. obesity: retatrutide phase 3 confirmed 30% bodyweight lost. 65% of patients no longer clinically obese. FDA submission late 2026
2. testosterone decline: FDA is expanding testosterone therapy. peptide and endocrine protocols going mainstream. the 1970 baseline is coming back.
3. birth rate crisis: embryo optimization commercially available today. scientists just rejuvenated aging human eggs in the lab. fertility is soon no longer a countdown
4. aging: Life Biosciences just injected the first reverse-aging drug into a human. Sinclair's oral reprogramming pill entering XPRIZE trials.
5. Alzheimer's: Retro Biosciences dosed the first humans with a pill that reactivates the brain's cellular cleanup machinery. Phase 1 results Q3 2026.
6. cancer: daraxonrasib nearly doubled survival in pancreatic cancer. RAS has been undruggable for 40 years. they drugged it.
7. mental health: psychedelics got a presidential executive order. Compass weeks from the first FDA approval of psilocybin.
8. heart disease: inflammation replacing cholesterol as the primary target. the root cause is finally being treated not the symptom.
every single one of these has a clinical trial or an FDA action behind it right now
humanity is slowly healing
bio/acc
are you paying attention chad?
the anti-aging and human enhancement arms race just went geopolitical
- Russia committed $26B. Putin made longevity a Kremlin priority. organ printing, genetics, cryotherapy.
- China published a 5-year national biotech plan. gene therapy, BCIs, AI drug discovery. genuine human firsts, not me-too drugs.
- UAE launched a national longevity program backed by sovereign wealth. zero taxes. fastest clinical trial approvals in the world.
- Singapore is funding longevity research at the state level and recruiting the world's best biotech founders.
and the private sector is not waiting
- Life Biosciences just injected the first reverse-aging drug into a human
- NewLimit raised $435M from Peter Thiel's Founders Fund. Brian Armstrong's bet on age reprogramming is moving from lab to clinic.
- Retro Biosciences raised $1.8B. Sam Altman's bet on adding 10 healthy years to human lifespan is scaling.
- Isomorphic Labs raised $2.1B. Demis Hassabis betting AI designs drugs better than humans.
- Neuralink has 21 implants in humans. Merge Labs launched with $252M. the BCI race is real.
- Altos Labs. $3B from Bezos. cellular rejuvenation. the largest single longevity round ever.
every major power and every serious founder on earth is pointing at the same problem
the race has begun
bio/acc
"ADAPT is not just a technology project - it is a trade competitiveness instrument."
Wamkele Mene, Secretary General of @AfCFTA, on why digital public infrastructure is at the centre of Africa's trade transformation - and why ADAPT is built to deliver it.
avax hit a new all-time low today alongside ada, dot, apt, op, fil, pol, xtz, zen. 8 alt L1s and infra tokens printing fresh lows simultaneously. capital is not rotating into alt L1s, it is leaving. same day a nasdaq-listed avax proxy ($AVAT) starts trading, the underlying sets a new floor. brutal timing for treasury co plays trying to front-run a bounce that keeps not coming. 95.4% below ATH at $6.65 with a $2.87b mcap, this is what a full sector unwind looks like.